Companies Economy International The Buzz Street Sweep Corrections Pre-market Trading After-hours Trading US Stocks Bonds and Interest Rates Currencies Commodities Mutual Funds World Markets Subscribe to Real Money Newsletter Subscribe to Money Magazine Money Magazine Real Estate Taxes Jobs Ask the Expert Money 101 Autos Mutual Funds The Help Desk Loan Center Best Places to Live Subscribe to Money Magazine Ask the Expert Ultimate Guide to Retirement Retirement Calculators Rules of Retirement Best Funds Best Places to Retire Fortune Tech Apple 2.0 Google 24/7 Techmate Tech Talk Questions & Answers Innovation Nation Small Business Video 50 Best Places to Launch Resource Guide Next Little Thing Subscribe to Fortune Magazine Fortune 500 Fortune Tech Investing Management Executive Interviews Rankings Log in Register Log Out Profile Alerts Newsletters My Watchlist

Boston Scientific sinks on FDA review foulup

By Ben Rooney, staff reporter


NEW YORK (CNNMoney.com) -- Shares of Boston Scientific fell sharply Monday after the biotechnology company said it has stopped delivery of certain implantable devices for patients with heart disease.

The Natick, Mass-based company's stock was down 16% to $6.50 in morning trading.

bsx.mkw.gif

The company said it has identified two instances when changes in the manufacturing process for the devices were not submitted for approval to the U.S. Food and Drug Administration.

"A planned process review revealed that two manufacturing process changes were not submitted for FDA approval," said Boston Scientific chief executive Ray Elliott in a statement. "We apologize for the inconvenience these actions will cause patients and physicians."

Boston Scientific said it has no indication that the changes pose any risk to patient safety. The company said it has informed the FDA of the problem and plans to work closely with the agency to resolve this situation as soon as possible.

The devices in question, cardioverter defibrillators and cardiac resynchronization therapy defibrillators, are surgically implanted and are designed to help patients with chronic heart disease. The company said it does not recommend "explantation" of the devices.

The company said its pacemakers and other products are not affected by Monday's advisory.

Boston Scientific (BSX, Fortune 500) warned that the move could have a "material impact" on its previously issued forecasts for revenue and profit. It plans to "fully evaluate" the impact of the actions on its financial results and provide an update when the evaluation is completed. To top of page

States are broke. You're on the hook.
States are borrowing from Peter to pay Paul. Debt burden is up 10% and expected to climb further. Your tab for all this: $936, on a national average. More
Foreclosed, homeless, but fortunate
Shari and Ken Muhammad's house fell into foreclosure, forcing the family of eight into homelessness for a cold, winter month. Play
Kindle 3: Endgame for e-reader wars?
With its WiFi-only Kindle 3 priced at $139, Amazon jumped to the front of a fast-changing market.  More
Markets Last Change % Change
Dow 10,465.94 -1.22 -0.01%
Nasdaq 2,254.70 3.01 0.13%
S&P 500 1,101.60 0.07 0.01%
Treasurys 2.91 -0.09 -3.07%
U.S. Dollar 1.31 -0.00 -0.23%
Data as of 11:43pm ET
Company Price Change % Change
Citigroup Inc 4.10 -0.02 -0.49%
Bank of America Corp... 14.04 0.01 0.07%
Ford Motor Co 12.77 -0.20 -1.54%
Microsoft Corp 25.81 -0.22 -0.85%
Sprint Nextel Corp 4.57 -0.19 -3.99%
Data as of Jul 30
Sponsors

Sections

Russian energy giant Gazprom tops the list, while BP and Toyota round out the top 5. More

Sure, the GDP report showed the economy is slowing. But the good news for the long term is that consumers are acting responsibly. Spending is moderate and savings are up. More

Microsoft CEO Steve Ballmer said the company needs to create a host of iPad competitors, but he gave no timeline for when they'll come to market. More

Kenneth Feinberg is working overtime to make sure that Gulf area businesses know him, and although obstacles loom, locals express confidence in him. More

Stay in a house or apartment instead. You'll save big money -- and have a more authentic experience. More

Please create a screen name to access this feature.

Screen name (Select one with 3-12 characters; Numbers and letters only)


Forgot password

Enter your e-mail address below and we will send you an e-mail with a link and code to reset your password.

E-mail

Already have the reset code?

Password selection

E-mail

Reset code

New password

Log in & let's get started!

E-mail

Password

Forgot password?


Not a member yet?

Sign up now for a free account

Sign up or log in

Screen name

Select one with 3-12 characters;
Numbers and letters only

E-mail

Make sure you typed it correctly.
You will receive an e-mail to validate your account

Password

Make it 6-10 characters, no spaces

We're Sorry!

This service is temporarily unavailable. Please try again soon.


 

 


Thanks!

Please check your e-mail and click the link to confirm your membership. Then, you'll be ready to participate in all activities and conversations on our site.

Go to your Profile page


© 2010 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy. Advertising Practices.
Home Portfolio Calculators Contact Us Newsletters Podcasts RSS Mobile Widgets Site Map User Preferences Advertise with Us
Magazine Customer Service Download Fortune Lists Reprints Career Opportunities Special Sections Conferences Business Leader Council
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer
LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer.
Morningstar: © 2010 Morningstar, Inc. All Rights Reserved. Disclaimer
The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2010 is proprietary to Dow Jones & Company, Inc
Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.
FactSet Research Systems Inc. 2010. All rights reserved.